Fushilai Pharmaceutical Gets Regulatory OK for Shenzhen IPO-- Suzhou Fushilai Pharmaceutical has gained approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission for its proposed listing on the bourse’s ChiNext board. The...